Understanding cholesterol: what LDL, HDL and ApoB reveal about heart health

Cholesterol does not have a particularly good reputation. Yet the body needs this fat-like substance to build cell membranes, produce hormones and form vitamin D. Problems arise above all when certain cholesterol-carrying particles circulate in the blood in excessive numbers over a prolonged period. They can accumulate in blood vessel walls and thus contribute to the development of cardiovascular disease.

In a blood test, attention usually turns first to total cholesterol, LDL and HDL. But these values do not tell the whole story. ApoB can also provide important clues about personal cardiovascular risk. What matters is not only how much cholesterol is present in the blood, but also how it is transported and which other risk factors play a role.

Contents

1. Why the body needs cholesterol
2. LDL and HDL: what the two values really tell us
3. ApoB: why the number of particles can be crucial
4. How atherosclerosis develops
5. Which cholesterol values are useful?
6. What influences cholesterol levels
7. Cholesterol in everyday life: how diet and exercise contribute
8. When cholesterol-lowering medicines may be considered
9. What cholesterol reveals about healthy ageing
10. References

Why the body needs cholesterol

The human body could not function without cholesterol. It is an important component of cell membranes and influences how stable and flexible they are. The body also needs cholesterol as a starting material for various hormones, bile acids and vitamin D.

Much of the cholesterol needed is produced by the liver itself. The body obtains another portion from food. How much cholesterol circulates in the blood therefore depends not only on diet, but also on how the body produces, absorbs and excretes cholesterol.

Because cholesterol is not water-soluble, it cannot simply be transported freely in the blood. It needs special transport particles known as lipoproteins. They consist of fats and proteins and carry cholesterol and other lipids to different tissues or back to the liver.

These particles differ in their composition and function. Particularly relevant to heart health are LDL and HDL. Other lipoproteins, including lipoprotein(a), can also influence the risk of cardiovascular disease.

Cholesterol itself is therefore not the problem. What matters is which lipoproteins carry it, how many are present in the blood and how long blood vessels are exposed to them.

LDL and HDL: what the two values really tell us

When cholesterol is discussed, the terms LDL and HDL usually come up. They are often called ‘bad’ and ‘good’ cholesterol. This simplification can help as an introduction, but falls short medically. LDL and HDL are not different types of cholesterol, but lipoproteins that transport cholesterol.

LDL cholesterol: why the value matters

LDL stands for Low-Density Lipoprotein. Among other things, these particles transport cholesterol from the liver to the body's cells. If the concentration of LDL in the blood is elevated, particles are more likely to enter the blood vessel wall and be retained there.

There, they can trigger processes that promote inflammatory responses and the formation of atherosclerotic plaques. These deposits can narrow blood vessels and alter their structure. If plaques rupture, a blood clot can form, partially or completely blocking a vessel.

Persistently elevated LDL cholesterol is a major, scientifically well-established risk factor for atherosclerotic cardiovascular disease. Examples include heart attacks and certain forms of stroke.

As a general rule, the greater and longer the exposure to LDL particles, the higher the long-term risk may be. However, the significance of a particular LDL value also depends on the overall risk profile.

HDL cholesterol: what the value reveals

HDL stands for High-Density Lipoprotein. Among other things, HDL particles are involved in the reverse transport of cholesterol from tissues and other parts of the body to the liver. There, it can be processed further and some of it excreted through the bile.

A low HDL cholesterol value is often associated with increased cardiovascular risk. However, this does not automatically mean that the highest possible value protects against disease. HDL performs various functions, and the measured amount of cholesterol does not fully reflect how well the particles actually work.

Medicines that specifically raise HDL levels have therefore not automatically also reduced the risk of heart attacks or strokes.

A high HDL value does not simply offset elevated LDL cholesterol. LDL, other lipid values and individual health factors must be considered together when assessing risk.

ApoB: why the number of particles can be crucial

Alongside LDL and HDL, ApoB is becoming increasingly important in assessing cardiovascular risk. The abbreviation stands for apolipoprotein B. This protein is found on certain lipoproteins, including LDL, VLDL and lipoprotein(a).

Each of these atherogenic lipoprotein particles carries one ApoB molecule. The ApoB concentration can therefore provide an approximate measure of how many of these particles circulate in the blood.

Why is this interesting? The LDL cholesterol value, often given as LDL-C, measures the amount of cholesterol transported in LDL particles. But it does not directly indicate how many particles are responsible. Two people can have similar LDL-C values even though their numbers of atherogenic particles differ.

This is particularly relevant when particles contain different amounts of cholesterol. With elevated triglycerides, insulin resistance or certain metabolic changes, the amount of cholesterol per particle can vary. In such cases, ApoB can provide additional information.

LDL-C describes how much cholesterol is transported in LDL. ApoB provides clues about how many atherogenic particles are circulating in the blood. The two values therefore examine different aspects of lipid metabolism.

ApoB does not generally replace the usual cholesterol values. Whether an additional measurement is useful depends, among other things, on previous laboratory results and the personal risk profile. In certain metabolic disorders, or when the values do not give a clear picture, ApoB can help with medical assessment.

Lipoprotein(a): an additional risk factor

Another value that can play a role in assessing cardiovascular risk is lipoprotein(a), or Lp(a) for short. Its structure resembles that of an LDL particle, but it also carries a special protein called apolipoprotein(a).

The concentration of Lp(a) is largely genetically determined and usually remains relatively stable in adulthood. Diet and exercise generally have only a limited influence on it.

A significantly elevated Lp(a) value can further increase the risk of atherosclerotic cardiovascular disease. It can therefore be useful to have it measured at least once in adulthood. This may be particularly relevant with a family history or unexpectedly high cardiovascular risk.

Whether and how often Lp(a) should be measured is best discussed with a doctor in light of the individual situation.

How atherosclerosis develops

Atherosclerosis usually develops over many years. The artery walls change and deposits form, known as plaques. It is often referred to colloquially as hardening of the arteries. In fact, however, it is a complex process involving lipoproteins, immune cells, inflammatory responses and other factors.

One of the initial steps is the entry of atherogenic lipoproteins into the inner layer of the blood vessel wall. If these particles are retained there, they can trigger changes to which the immune system responds. Certain immune cells absorb the fats they contain. As the process continues, deposits and areas of inflammation can form.

Over time, plaques form that can grow and alter the blood vessel wall. Some remain stable for a long time, while others can rupture. If a blood clot forms in the process, blood flow can suddenly become severely restricted.

The consequences depend on which vessel is affected. In the coronary arteries, such a blockage can trigger a heart attack. If vessels supplying the brain are affected, an ischaemic stroke can occur.

An important point is that atherosclerosis often causes no noticeable symptoms for a long time. A person can feel fit while already having changes in their blood vessels.

Feeling physically well alone therefore tells us little about actual cardiovascular risk. Laboratory values can help identify risk factors early, before symptoms appear.

Alongside LDL and other atherogenic lipoproteins, high blood pressure, smoking, diabetes, age and genetic factors also influence the development of atherosclerosis. The interplay of several factors is therefore always crucial.

Which cholesterol values are useful?

Blood tests often measure total cholesterol, LDL-C, HDL-C and triglycerides. Depending on the starting situation, other values such as non-HDL cholesterol, ApoB or lipoprotein(a) may be added.

The results cannot be assessed independently of one another. A single value describes only one part of lipid metabolism. For medical interpretation, relevant factors include pre-existing conditions, blood pressure, smoking status, diabetes, family history and previous cardiovascular risk.

Which LDL targets apply?

There is no single LDL-C target that applies equally to everyone. European guidelines are based on individual cardiovascular risk. The higher this risk, the lower the target LDL value generally is.

The following values correspond to the targets used in European guidelines for different risk groups:

These targets are points of reference, not a basis for blanket self-diagnosis. Classification into a risk group is based on various factors. People with existing atherosclerotic cardiovascular disease often have stricter treatment targets than people without known vascular disease.

The current medical guidelines must also be taken into account. A doctor should assess which targets are appropriate in each case and whether treatment is needed.

An LDL value that may be sufficient for one person may be too high for another with existing vascular disease. It therefore makes little sense to compare laboratory values solely with general reference ranges.

What influences cholesterol levels

The level of cholesterol in the blood depends on several factors. These include genetic predisposition, diet, age, hormonal changes, certain diseases and medicines.

Genetic predisposition

Some people naturally have higher LDL values than others. A well-known example is familial hypercholesterolaemia. In this condition, genetic changes mean that LDL is removed from the blood less effectively. Cholesterol levels can therefore be significantly elevated from a young age.

Such a predisposition often goes unnoticed in everyday life for a long time because high cholesterol levels do not cause typical immediate symptoms. Clues may include very high LDL values or cardiovascular disease in close relatives at a comparatively young age.

If this is suspected, medical assessment can be important. Depending on the findings, further investigations and, where appropriate, tests in family members may be considered.

Age and hormonal changes

Cholesterol levels can change over the course of life. LDL values rise in many people as they age, although the pattern varies from person to person.

Hormonal changes also play a role. In women, the lipid profile can change around menopause. LDL values often rise during this time. The extent of the changes depends on various individual factors.

This does not mean that elevated cholesterol levels in older age should simply be accepted. Rather, they need to be considered in the context of overall health and personal risk.

Metabolism and other diseases

Metabolic changes can also affect blood lipids. These include insulin resistance, type 2 diabetes and certain thyroid diseases, for example. Depending on the cause, LDL cholesterol, triglycerides or other lipid values may be altered.

Elevated triglycerides occur more frequently, for example, with insulin resistance, regularly high alcohol consumption or certain dietary habits. Genetic factors can also play a role.

Some medicines also influence lipid metabolism. If values are abnormal, it can therefore be useful to review possible causes with a doctor.

Not every elevated cholesterol value has the same cause. A good assessment therefore takes into account not only the measured value, but also medical history and possible influencing factors.

Cholesterol in everyday life: how diet and exercise contribute

Although genetic predisposition plays an important role, lifestyle can influence lipid metabolism. Diet, exercise, smoking, alcohol and body weight can affect various blood lipid values and cardiovascular risk.

The quality of fats is crucial

For LDL cholesterol levels, it matters not only how much fat is eaten, but also which fats are on the menu. Replacing larger amounts of saturated fatty acids with unsaturated fatty acids can lower the LDL value.

Saturated fatty acids are found in butter, high-fat dairy products, fatty meat and some tropical vegetable fats, among other foods. Unsaturated fatty acids are found, for example, in olive oil, rapeseed oil, nuts, seeds and oily fish.

This does not mean that individual foods must be completely forbidden. It is often more helpful to look at the diet as a whole and regularly replace certain foods with more beneficial alternatives.

Fibre supports lipid metabolism

Dietary fibre can also contribute. Soluble fibre in particular, such as that found in oats, pulses and certain fruits, can lower LDL cholesterol levels.

It can form gel-like structures in the digestive tract and influence the absorption of bile acids. As the body makes new bile acids from cholesterol, among other substances, this can alter cholesterol metabolism.

A diet containing vegetables, fruit, wholegrain products, pulses and nuts also provides other nutrients that are important for general health.

Exercise and body weight

Regular exercise has a positive effect on various aspects of cardiovascular health. Among other things, it can improve blood pressure, insulin sensitivity and physical performance. Triglyceride values can also benefit.

Its effect on LDL cholesterol, however, varies. Exercise alone does not lead to a significant reduction in LDL in everyone. Nevertheless, it is an important part of a heart-healthy lifestyle.

In people who are overweight or have substantial abdominal fat, weight loss can improve blood lipid values and other metabolic parameters. The aim is not short-term dieting, but changes that can be integrated into everyday life over the long term.

Alcohol and smoking

Regularly high alcohol consumption can increase triglyceride values in particular. People with elevated triglycerides should therefore also take alcohol consumption into account during medical assessment.

Smoking influences cardiovascular risk on several levels. It damages blood vessels and increases the risk of heart attacks and strokes. Stopping smoking is therefore an important measure for vascular health, regardless of cholesterol levels.

Diet and exercise can achieve a great deal, but with significantly increased risk they do not automatically replace medically recommended treatment. Which measures are sufficient depends, among other things, on baseline values and any pre-existing conditions.

When cholesterol-lowering medicines may be considered

If LDL cholesterol is significantly elevated or overall cardiovascular risk is high, medicines may be useful. This is particularly true for people who have already had a heart attack or stroke, or who have been diagnosed with substantial vascular disease.

Whether medication is an option is not decided on the basis of a single laboratory value alone. Doctors consider individual risk, possible underlying conditions, previous treatment attempts and the intended LDL targets, among other factors.

Statins as commonly used medicines

Statins are among the most commonly used medicines for lowering LDL cholesterol. They inhibit an enzyme that the liver needs to produce cholesterol. As a result, the liver produces less cholesterol and takes up more LDL particles from the blood.

The effectiveness of statins has been investigated in numerous studies. In people with the relevant risk, they can reduce the likelihood of certain cardiovascular events.

As with all medicines, side effects can occur. These include muscle symptoms, for example. Whether symptoms are actually related to the medicine must be assessed in each case. Treatment should therefore be supervised by a doctor and reviewed together if problems arise.

Other options for lowering LDL

If statins do not work sufficiently, are not tolerated or do not achieve the intended treatment target, other medicines may be considered.

Ezetimibe reduces the absorption of cholesterol in the intestine. PCSK9 inhibitors influence a mechanism that regulates the breakdown of LDL receptors in the liver. This allows the liver to remove more LDL from the blood. Other active substances may also be considered depending on the situation.

Which treatment is suitable depends on personal risk, baseline LDL values, possible coexisting conditions and tolerability.

It is also important to distinguish between a change in a laboratory value and a proven health benefit. Successful LDL reduction is an important treatment goal, but treatment is always assessed in the context of overall cardiovascular risk.

Medication and lifestyle measures are not mutually exclusive. Diet, exercise and avoiding smoking remain important parts of prevention even during drug treatment.

What cholesterol reveals about healthy ageing

Healthy ageing means more than living as long as possible. It is equally important to remain physically and mentally capable for as long as possible and to prevent avoidable diseases. Cardiovascular health plays a central role in this.

Atherosclerotic changes often develop over decades. Persistently elevated LDL cholesterol can promote this process long before the first symptoms appear. It can therefore be useful to check blood lipids before health problems develop.

The aim is not to keep a single laboratory value as low as possible without considering the context. Rather, personal risk should be assessed realistically. Alongside LDL and, where appropriate, ApoB, this includes blood pressure, blood sugar, smoking habits, exercise, family history and existing diseases.

The long-term perspective is also important. A single normal cholesterol value does not guarantee permanently healthy blood vessels. Conversely, an elevated value does not automatically mean that vascular disease is already present. It can, however, indicate that a more detailed assessment would be useful.

People who know their values can decide together with healthcare professionals whether changes in everyday life are sufficient or whether further investigations and treatment are indicated.

For long-term vascular health, what matters is not just a single cholesterol value, but the interplay between the lipid profile, other risk factors and the duration of exposure. LDL-C provides important information for this. ApoB and, where appropriate, lipoprotein(a) can offer additional clues when relevant to the individual situation.

Understanding cholesterol therefore means, above all, considering the values in the right context. This makes it possible to identify potential risks early and choose measures that suit one's own health and life circumstances.

References

1. Mach, F. et al. (2020). 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk. European Heart Journal, 41(1), 111–188.
2. European Society of Cardiology (2025). 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias. European Heart Journal, 46(42), 4359–4400.
3. Borén, J. et al. (2020). Low-Density Lipoproteins Cause Atherosclerotic Cardiovascular Disease: Pathophysiological, Genetic, and Therapeutic Insights. European Heart Journal, 41(24), 2313–2330.
4. Ference, B. A. et al. (2017). Low-Density Lipoproteins Cause Atherosclerotic Cardiovascular Disease. 1. Evidence from Genetic, Epidemiologic, and Clinical Studies. A Consensus Statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal, 38(32), 2459–2472.
5. Sniderman, A. D. et al. (2019). Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiology, 4(12), 1287–1295.
6. Wilson, P. W. F. et al. (2022). Lipid Management in Patients with Cardiovascular Disease and Other High-Risk Conditions: A Scientific Statement from the American Heart Association. Circulation.